Boron Neutron Capture Therapy Market Outlook From 2026 To 2030: Key Growth Factors And Future Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Boron Neutron Capture Therapy Market Growth Potential: How Will Market Size Shift Through 2030?
The boron neutron capture therapy market has experienced rapid expansion in recent years. It is projected to expand from $0.12 billion in 2025 to $0.15 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. Historically, this growth can be ascribed to increasing prevalence of cancer cases, early development of neutron capture research, adoption of reactor-based radiation therapies, growth in oncology clinical research, and rising government funding for cancer treatment studies.
The boron neutron capture therapy market size is anticipated to expand substantially over the next few years. It is projected to reach $0.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.7%. This expansion during the forecast period is primarily driven by the increasing integration of precision medicine approaches, a growing shift towards targeted cancer therapies, the proliferation of accelerator-based BNCT systems, escalating investment in oncology research and development infrastructure, and more frequent regulatory approvals for advanced radiotherapy techniques. Noteworthy trends expected in this period include the wider acceptance of accelerator-based BNCT systems, the expanding utilization of next-generation boron delivery agents, an intensified focus on precision oncology treatment methods, advancements in neutron beam optimization technologies, and a surge in clinical trials for both brain and extracranial tumor applications.
Get A Free Sample Report With In-Depth Market Insights:
Boron Neutron Capture Therapy Market Growth Catalysts And Demand Drivers
The increasing global prevalence of cancer is expected to propel the growth of the boron neutron capture therapy market going forward. Cancer is a condition where abnormal cells grow uncontrollably and spread within the body, disrupting and damaging normal tissues. The growing incidence of cancer is driven by lifestyle risk factors such as tobacco use, poor diet, and physical inactivity, which cause chronic inflammation and genetic mutations that increase cancer risk over time. Boron neutron capture therapy supports cancer treatment by providing a targeted radiation approach that selectively destroys tumor cells while minimizing damage to surrounding healthy tissues, making it suitable for difficult or recurrent cancers. For instance, in February 2024, according to the World Health Organization, a Switzerland-based global health agency, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing global prevalence of cancer is driving the growth of the boron neutron capture therapy market.
Boron Neutron Capture Therapy Market Breakdown By Product Type And Application
The boron neutron capture therapy market covered in this report is segmented –
1) By Type: Thermal Beam, Epithermal Beam
2) By Boron Agent Type: Boronophenylalanine (BPA), Sodium Borocaptate ( BSH), Next-Generation Boron Delivery Agents
3) By Technology: Reactor-Based Boron Neutron Capture Therapy, Accelerator-Based Boron Neutron Capture Therapy
4) By Application: Brain Tumor, Extracranial Tumor, Other Applications
5) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users
Subsegments:
1) By Thermal Beam: Thermal Neutron Beam Delivery Systems, Thermal Neutron Treatment Platforms
2) By Epithermal Beam: Epithermal Neutron Beam Delivery Systems, Epithermal Neutron Treatment Platforms
Boron Neutron Capture Therapy Market Trends Shaping Long-Term Demand
Major companies operating in the boron neutron capture therapy market are prioritizing the advancement of novel boron delivery agents to enhance tumor targeting, improve imaging accuracy, and support effective therapeutic outcomes. These innovative boron delivery agents are specialized compounds engineered to selectively deliver and concentrate boron in tumor cells, thereby boosting the precision and therapeutic effectiveness in boron neutron capture therapy. For instance, in January 2025, Neuboron Medtech Ltd., a China -based R&D-oriented medical technology company, achieved IND approval for ¹8F-BPA, marking a key regulatory milestone in BNCT development. This highlights a rare combination of regulatory progress and clinical advancement, accelerating the translation of BNCT from research to real-world oncology applications.
Boron Neutron Capture Therapy Market Key Participants And Competitive Landscape
Major companies operating in the boron neutron capture therapy market are Hitachi Ltd., Mitsubishi Heavy Industries Ltd., Sumitomo Heavy Industries Ltd., RaySearch Laboratories AB, Toshiba Energy Systems & Solutions Corporation, Cancer Intelligence Care Systems Inc., Neuboron Medtech Ltd., TAE Life Sciences LLC, Neutron Therapeutics Inc., Katchem Ltd., Stella Pharma Corporation, Fukushima SiC Applied Engineering Inc., International Particle Therapy Inc., Aviko Radiopharmaceuticals Sp. z o.o., Helsinki University Hospital, University of Wisconsin–Madison.
View The Full Boron Neutron Capture Therapy Market Report:
Boron Neutron Capture Therapy Market Geographic Analysis: Where Is Demand Rising Fastest?
Asia-Pacific was the largest region in the boron neutron capture therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the boron neutron capture therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
